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We report the outcome of the iliac vein approach for permanent pacemaker implantation in
4 patients in whom the conventional pectoral approach was not possible. The reasons for
using the iliac vein approach were: recurrent lead infections at bilateral pectoral positions in 1
patient; superior vena cava obstruction following cardiac surgery in 2 patients; and a
postoperative dermal scar due to right radical mastectomy secondary to a persistent left
superior vena cava with absence of the innominate vein in 1 patient. This technique was safe
and eﬀective during the mean follow-up period of 24.3 months. At the latest follow-up, no
patients showed signs of electrophysiological abnormalities. No short- or long-term
complications were seen. Conclusions: The iliac vein approach is a less invasive and more
feasible alternative without any complications for patients in whom the pectoral approach
cannot be used.
(J Arrhythmia 2010; 26: 55–61)
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When implantation of transvenous pacing leads
via the superior vena cava (SVC) is not possible or
contraindicated, the majority of such patients under-
go thoracotomy for surgical placement of the
epicardial leads. However, the epicardial approach
has inherent problems, including the need for general
anesthesia and concerns regarding long-term electro-
physiological performance of the epicardial leads.
The iliac vein approach appears to be a less invasive
and feasible alternative to the epicardial approach.
The present report demonstrates the eﬀectiveness of
the iliac vein approach for patients in whom the
pectoral approach was not possible or suboptimal.
Case Reports
We have performed four pacemaker implantations
in four patients using the iliac vein approach
between January 2004 and December 2008. All
patients were followed up in the outpatient clinic at
6-month intervals.
Implantation procedure
Under local anesthesia, an oblique incision
was made cranial and parallel to the inguinal
ligament and slightly medial to the femoral artery
(Figure 1a, b). Bilateral iliac veins were available for
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lead implantation. The inguinal ligament was dis-
sected, and an external iliac vein was directly
exposed. One or two 4-0 monoﬁlament horizontal
mattress sutures with pledgets for hemostasis were
placed on the exposed external iliac vein, corre-
sponding to the intended number of leads to be
implanted. The exposed iliac vein was directly
punctured and cannulated with a split sheath using
a modiﬁed Seldinger technique to introduce the
pacing lead. To advance the lead into the endocardial
surface of the heart, 25-cm-long split sheaths
(Medikit, Inc. Tokyo, Japan) proved useful. The
leads used in the present report were 4 active ﬁxation
leads (CAPSUREFIX NOVUS 5076, Medtronic,
Inc. Minneapolis, MN, USA) and 1 passive ﬁxation
lead (CAPSURESP NOVUS 4092, Medtronic,
Inc.). All leads were 85 cm long. When a lead was
implanted into the right atrium, a loop was made by
the lead in the right atrium to prevent the atrial lead
from dislodgement, the tip of the electrode was
positioned in an area where the atrial wall had
conditions suﬃcient for sensing and pacing, and then
the atrial lead was screwed to the right atrial wall
(Figure 2a, b). Ventricular leads were advanced into
the right ventricular apex, in the same manner as in
the pectoral approach. A subcutaneous pocket for the
device was created with another incision, superﬁcial
to the deep fascia and cranial to the previous
incision. The lead was secured to the fascia and
pulled through a tunnel into the subcutaneous pocket
and then connected to a pulse generator. Strong
generator ﬁxation is necessary to prevent the
possibility of subsequent gravity-dependent migra-
tion of the device to the inguinal ligament. The
patient was maintained on bed-rest for 24 hours and
then gently mobilized. Prophylactic anticoagulant
(warfarin potassium) was administered to selected
patients whom deep vein thrombosis or edema in
their lower extremities was anticipated postopera-
tively. Based on the published literature, the risk of
asymptomatic deep vein thrombosis following the
iliac vein approach is similar to that of asymptomatic
subclavian vein thrombosis associated with trans-
venous pacing via the pectoral approach.1)
Case 1
A 79-year-old woman with complete atrioventric-
ular block (c AVB) was referred for permanent
pacemaker implantation. She had a history of
cerebral infarction and right radical mastectomy
with right axillary lymph node dissection. Permanent
pacemaker implantation was attempted with the
Figure 1a
The anatomy of the venous system of the lower extremity is
shown. An incision just above the inguinal ligament is also shown.
Figure 1b
The run of the transiliac ventricular lead and the position of the
generator are shown in the abdominal roentgenogram. The arrow
shows the puncture site.
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usual left pectoral approach. After insertion of a
guide wire in the left subclavian vein, the guide wire
could not pass the innominate vein, and the passage
of the guide wire suggested the presence of a
persistent left SVC (PLSVC). Left subclavian ve-
nography conﬁrmed the presence of the PLSVC with
absence of an innominate vein. Moreover, there was
stenosis in the mid-portion of the PLSVC (Figure 3).
Therefore the pectoral approach was suspended. Her
age and impaired condition (almost bedridden)
increased the risks associated with using general
anesthesia. We elected to implant a transvenous
pacing system via the iliac vein approach as a less
invasive treatment. A right pectoral approach with
generator implantation at the back of the right
shoulder was not performed because such implanta-
tion has a risk of compression necrosis.
Case 2
A 77-year-old woman had a DDD pacemaker
implantation for c AVB 16 years earlier. Pacemaker
infection necessitated explantation of this system
and implantation of a new VVI pacemaker on the
contralateral side 5 years earlier. Infection and
erosion of her pacemaker on the right side had
developed at the present admission. Because of the
previous pacemaker infection, a total of 3 endocar-
dial electrodes were introduced into the SVC via a
bilateral pectoral approach. Considering her severely
impaired condition (bedridden due to sequelae of
severe cerebral infarction), less invasive treatment
was chosen instead of radical surgery, such as
removal of the implanted electrodes using open-
heart surgery. The removal of the infected pace-
maker system on the right side was performed, but
the lead remnants remained in the SVC. Further
implantation of an endocardial electrode into the
SVC was not performed. Therefore, a new pace-
maker system was later implanted using the iliac
vein approach after recovery from the infection.
Case 3
A 68-year-old woman with a history of mitral
valve replacement had a pacemaker implantation for
symptomatic (recurrent faintness) atrial ﬁbrillation
with low ventricular response. Although the usual
left pectoral approach was attempted, following the
insertion of a guide wire into the left subclavian
vein, the guide wire could not pass the SVC.
Venography suggested the presence of stenosis at
the SVC. Therefore, the pectoral approach was
suspended. Computed tomography (CT) showed that
there was diﬀuse stenosis at the SVC, which
appeared to be the cause of the thrombus, due to
direct SVC cannulation or repeated insertion of
central venous catheters perioperatively (Figure 4).
Figure 2b
Lateral projection of a chest roentgenogram also shows that the
atrial lead makes a loop in the right atrium.
Atrial lead
Figure 2a
Postero-anterior projection of a chest roentgenogram shows
transiliac atrial and ventricular leads in the right atrium and right
ventricular apex. The atrial lead makes a loop in the right atrium.
Atrial lead
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Based on these ﬁndings, the pectoral approach was
abandoned and pacemaker implantation using the
iliac vein approach was elected.
Case 4
A 34-year-old woman was treated for c AVB
following the Mustard operation for transposition of
the great arteries with a VVI pacemaker 29 years
earlier. As she was a child at the time of the
pacemaker implantation, an epicardial pacing system
was implanted with the pulse generator located in the
left hypochondrium. The previously implanted epi-
cardial lead showed lead fracture with elevation in
the pacing threshold. According to documentation in
her medical chart, several attempts were made to
implant a permanent pacemaker using a transvenous
pacing system via the usual pectoral approach in the
past, but the endocardial electrode could not pass the
junction between the SVC and the right atrium. The
Mustard operation is known to cause intra-atrial
stenosis, especially in the SVC, due to the presence
of the intra-atrial baﬄe. Based on these ﬁndings, the
pectoral approach was abandoned and implantation
of a transvenous pacing system via the iliac vein
approach was initially scheduled. Since an atrial
switch operation had been performed, the tip of the
ventricular electrode was located at the apex of the
anatomical left ventricle.
Four patients had pacemakers implanted using the
iliac vein approach. Three pacemakers were single
chamber (VVI), and one was dual chamber (DDD).
Five leads (1 atrial and 4 ventricular) were implanted
(Table 1), and the majority of the leads were active
ﬁxation [1/1 (100%) atrial, 3/4 (75%) ventricular].
Performance of the implanted leads at implanta-
tion
During implantation, the mean ventricular R wave
amplitude was 8.8mV, the mean ventricular pacing
threshold expressed as calculated energy consump-
tion was 2.00 mJ, and the mean ventricular lead
impedance was 684.3 (Table 2). According to the
manufacturer’s information, the estimated standard
lead impedances that were used in the present report
were between 500 and 1000.
Performance of the implanted leads during
follow-up
The mean follow-up period was 24.3 months after
implantation. The mean ventricular sensing thresh-
old was 7.5mV, the mean ventricular pacing thresh-
Figure 3
Venography shows the PLSVC with absence of the innominate
vein (arrow), and stenosis at the mid-portion of the PLSVC.
PLSVC: persistent left superior vena cava
Figure 4
Coronal view of computed tomography shows that there is diﬀuse
stenosis in the SVC, which may have been due to diﬀuse
thrombosis in the SVC. The arrow shows the most stenotic site in
the SVC.
SVC: superior vena cava
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old expressed as calculated energy consumption was
2.89 mJ, and the mean ventricular lead impedance
was 629.0 (Table 2). The implanted atrial lead also
showed good performance without dislodgement. No
short- or long-term complications, including dis-
lodgement or fracture of the leads, infection, thresh-
old elevation, or development of deep vein throm-
bosis or edema in the lower extremities, were
observed.
Discussion
The group of patients presented here accounts for
1.4% of the 284 permanent pacemakers implanted
Table 2 Outcomes of the lead data
Case 1 2 3 4 mean
(Implant)
Pacing threshold
(Voltage/pulse width)
atrium 1.0 V/0.5 mS () () () 1.0 V/0.5 mS
ventricle 0.3 V/0.5 mS 0.75 V/0.4 mS 0.3 V/0.5 mS 0.75 V/0.5 mS 0.53 V/0.48 mS
ventricular pacing threshold
expressed as energy consumption (mJ) 0.62 3.82 0.63 3.97 2.00
P wave amplitude (mV) 1.8 () () () 1.8
R wave amplitude (mV) 9.9 10.5 9 5.6 8.8
Lead impedance (ohm)
atrium 584 () () () 584
ventricle 724 595 710 708 684
(Follow-up period)
Pacing threshold
(Voltage/pulse width)
atrium 1.3 V/0.4 mS () () () 1.3 V/0.4 mS
ventricle 0.5 V/0.5 mS 0.75 V/0.4 mS 0.6 V/0.4 mS 0.75 V/0.4 mS 0.65 V/0.43 mS
ventricular pacing threshold
expressed as energy consumption (mJ) 1.85 4.43 2.28 3.52 2.89
P wave amplitude (mV) 1.4 () () () 1.4
R wave amplitude (mV) 8.3 8 8 5.8 7.5
Lead impedance (ohm)
atrium 513 () () () 513
ventricle 673 571 631 639 629
Table 1 Patient characteristics
Case 1 2 3 4
Age (years) 79 77 68 34
Diagnosis cAVB cAVB brady Af cAVB
Indications for employing IVA PLSVC and
rt Mastectomy
Previous
infection
in SVC leads
postoperative
SVC stenosis
(Mitral valve
replacement)
postoperative
SVC stenosis
(TGA: Mustard
opeation)
Atrial lead model MD NOVUS 5076 () () ()
Ventricular lead model MD NOVUS 4092 MD NOVUS 5076 MD NOVUS 5076 MD NOVUS 5076
Type of implanted pacemaker DDD VVI VVI VVI
Follow-up period (months) 16 61 12 8
Postoperative complications () () () ()
IVA: iliac vein approach, cAVB: complete AtrioVentricular Block, brady Af: bradycardial Atrial ﬁbrillation, PLSVC: Patent Left
Superior Vena Cava, TGA: Transposition of the Great Arteries, rt: right, MD: Medtronic, SVC: Superior Vena Cava
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at Saiseikai Utsunomiya Hospital during the same
period. In the present report, the indication for
the iliac vein approach was venous or intra-atrial
obstructions in 2 patients that were considered to
have occurred as a result of cardiac surgery. One
patient underwent repeated attempts at SVC lead
implantation due to recurrent pacemaker infection.
Since the patient already had 3 leads in the SVC,
further lead insertion was inappropriate. Another
patient had thin right anterior chest skin due to a
right radical mastectomy secondary to congenital
PLSVC with absence of communication between the
right SVC and the PLSVC. Clinically, 1–6% of
patients who require permanent pacemaker implan-
tation have features that make the conventional
pectoral approach not possible or contraindicated
due to various reasons, including anatomical anoma-
lies, acquired subclavian vein or SVC occlusion,
repeated attempts at SVC lead implantation, and
inability to place a subdermal pouch on the anterior
chest wall due to thin skin.2–9) The insertion of a
permanent pacemaker in patients with these compli-
cations poses the practical problem of how to gain
access to the heart. Though implantation of trans-
venous pacing leads via the iliac vein is considered
an eﬀective alternative procedure in such patients,
the iliac vein approach is currently performed in a
limited number of institutions.2–9) The underutiliza-
tion of the iliac vein approach may be due to the fear
of possible complications associated with this ap-
proach, including lead dislodgement, lead fracture,
infection, and retroperitoneal hematoma.2–9) Lead
dislodgement, especially the atrial lead has been
considered the major complication associated with
this procedure. The incidence of atrial lead dislodge-
ment using this approach has been reported to range
from 7 to 21%.2–5) When an atrial lead is implanted
using the iliac vein approach, due to anatomical
morphology where the atrial lead runs from the
external iliac vein to the right atrium via the inferior
vena cava, the tip of the implanted atrial lead has to
continuously bear its own weight. This gravity-
dependent force continuously acts on the tip of the
implanted atrial lead to withdraw it from the site
where it is ﬁxed to the right atrial wall. Therefore,
the most important factor for avoiding dislodgement
of the implanted atrial lead using the iliac vein
approach is to prevent the tip of the atrial lead from
bearing its own weight. We believe that making a
loop in the right atrium prior to tightening the screw
of the atrial lead may serve this purpose. Septal
pacing has emerged as an eﬀective therapy for
patients with moderate to severe congestive heart
failure with prolonged QRS complexes. On the other
hand, there may be diﬃculty in the selection of the
pacing site via the iliac vein approach, especially for
right ventricular outﬂow tract (RVOT) pacing, due
to anatomical reasons. However, in one report the
ventricular lead was positioned at the right ventric-
ular septum using a 58-cm-long endocardial elec-
trode via the iliac vein approach.7) Septal pacing via
the iliac vein approach may not always be diﬃcult;
in particular, moderator band pacing may be possi-
ble. In the future, septal pacing via the iliac vein
approach may be necessary in order to obtain narrow
QRS complexes in selected patients with moderate-
to-severe congestive heart failure with prolonged
QRS complexes. To the best of our knowledge, no
literature has examined whether crossing the hip
joint may have a deleterious impact on lead
longevity due to hip joint ﬂexion. However, many
authors who have described the iliac vein approach
expressed concerns about the relation between lead
fracture and hip joint movement.2,4,8,9) It is uncertain
whether this complication rate is higher than that
for the pectoral approach. Further research is needed
to evaluate this complication via the iliac vein
approach. However, in order to allay concerns about
late lead fracture due to hip joint ﬂexion or lower
abdominal wall movement, we believe that direct
external iliac vein exposure from the cranial side to
the inguinal ligament is preferred. Blind puncture
may cause retroperitoneal bleeding or intestinal
injury. In our series, under local anesthesia, direct
access was obtained into the external iliac vein for
insertion of the leads without any complications.
Conclusions
We presented our experience using the iliac vein
approach for permanent pacemaker implantation in
patients in whom the conventional pectoral approach
was not possible. This approach appears not only
satisfactory for ventricular lead placement, but it is
also satisfactory for atrial lead placement with our
modiﬁcation. This approach appears to be a less
invasive and feasible alternative to epicardial lead
implantation.
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